Imetelstat is approved by FDA for low- to intermediate-1 risk myelodysplastic syndromes with transfusion-dependent anemia
May 2024: Imetelstat (Rytelo, Geron Corporation), an oligonucleotide telomerase inhibitor, has been approved by the Food and Drug Administration for use in adults with low- to intermediate-1 risk myelodysplastic syndrome..
Assela, Bone marrow transplant, Delhi, Ethiopia, India, Stem cell transplant
Bone marrow transplant in India – A patient story
This story is about bone marrow transplant in India. Mukhtar, who is from Assela in Ethiopia, suffers from deadly aplastic anemia. He travels to India for his stem cell transplant. Read the entire story here. Mukhtar Mukhtar is ..